Anthem, Inc. (NYSE:ANTM) shares reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $221.59 and last traded at $218.20, with a volume of 1190700 shares. The stock had previously closed at $218.45.
ANTM has been the subject of several research analyst reports. BidaskClub cut Anthem from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Zacks Investment Research upgraded Anthem from a “hold” rating to a “buy” rating and set a $212.00 price target for the company in a research report on Thursday, September 14th. Cantor Fitzgerald restated a “buy” rating and issued a $215.00 price target on shares of Anthem in a research report on Thursday, September 14th. Finally, Cowen and Company restated a “buy” rating and issued a $160.00 price target on shares of Anthem in a research report on Thursday, September 21st. Eight research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $197.69.
The company has a debt-to-equity ratio of 0.53, a current ratio of 1.51 and a quick ratio of 1.51. The firm has a market cap of $56,730.00, a price-to-earnings ratio of 17.53, a PEG ratio of 1.71 and a beta of 0.77.
The company also recently announced a quarterly dividend, which will be paid on Thursday, December 21st. Stockholders of record on Tuesday, December 5th will be given a $0.70 dividend. The ex-dividend date is Monday, December 4th. This represents a $2.80 annualized dividend and a dividend yield of 1.28%. Anthem’s payout ratio is 25.32%.
In other Anthem news, Director Julie A. Hill sold 1,602 shares of the business’s stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $215.70, for a total transaction of $345,551.40. Following the completion of the transaction, the director now owns 35,322 shares in the company, valued at approximately $7,618,955.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Joseph Swedish sold 21,125 shares of the business’s stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $190.63, for a total value of $4,027,058.75. The disclosure for this sale can be found here. In the last quarter, insiders sold 65,955 shares of company stock valued at $13,179,953. Insiders own 0.36% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the business. C M Bidwell & Associates Ltd. raised its stake in shares of Anthem by 0.5% in the 2nd quarter. C M Bidwell & Associates Ltd. now owns 1,070 shares of the company’s stock worth $201,000 after buying an additional 5 shares in the last quarter. Salem Investment Counselors Inc. raised its position in shares of Anthem by 1.4% during the second quarter. Salem Investment Counselors Inc. now owns 710 shares of the company’s stock worth $134,000 after purchasing an additional 10 shares during the period. Cedar Wealth Management LLC raised its position in shares of Anthem by 1.7% during the second quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock worth $171,000 after purchasing an additional 15 shares during the period. Gofen & Glossberg LLC IL raised its position in shares of Anthem by 0.6% during the second quarter. Gofen & Glossberg LLC IL now owns 2,540 shares of the company’s stock worth $478,000 after purchasing an additional 15 shares during the period. Finally, Dowling & Yahnke LLC raised its position in shares of Anthem by 0.3% during the second quarter. Dowling & Yahnke LLC now owns 7,175 shares of the company’s stock worth $1,350,000 after purchasing an additional 18 shares during the period. Institutional investors own 88.91% of the company’s stock.
Anthem Company Profile
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.